PACIFIC-Real World: First real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.

  • Moore, Maggie (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann, (Project Manager)

Project: Research

StatusActive
Effective start/end date7/08/1931/12/24

Keywords

  • Medical Oncology
  • Clinical trial